E-LIB Suche - Ergebnisse für: Navarro Brugal, Gemma

1

Cannabinoids as a potent therapeutic target for Alzheimer's..:

Brugal, Gemma Navarro ; Rivas‐Santisteban, Rafael ; Marquez, Alejandro Lillo..
Alzheimer's & Dementia. 18 (2022) S4 - p. , 2022

Link: https://doi.org/10.1002/..

2

P3‐214: ADENOSINE A2A RECEPTOR ACTIVATION ATTENUATES NMDA R..:

Brugal, Gemma Navarro ; Aguinaga, David ; Reyes, Irene...
Alzheimer's & Dementia. 15 (2019) 7S_Part_19 - p. , 2019

Link: https://doi.org/10.1016/..

3

P1‐242: INTERACTION BETWEEN N‐METHYL ASPARTATE (NMDA) GLUTA..:

Brugal, Gemma Navarro ; Aguinaga, David ; Reyes, Irene...
Alzheimer's & Dementia. 14 (2018) 7S_Part_7 - p. , 2018

Link: https://doi.org/10.1016/..

4

[P4–455]: NEUROPROTECTIVE EFFECT OF CANNABINOID RECEPTORS I..:

Brugal, Gemma Navarro ; Borroto‐Escuela, Dasiel ; Reyes, Irene...
Alzheimer's & Dementia. 13 (2017) 7S_Part_31 - p. , 2017

Link: https://doi.org/10.1016/..

5

THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATE..:

Garrido-Gil, Pablo ; Pérez, Ana Isabel Rodríguez ; Pedrosa, María A...
IBRO Neuroscience Reports. 15 (2023) - p. S412-S413 , 2023

Link: https://doi.org/10.1016/..

6

ASTROGLIAL CB1R-A1R AND CB1R-A2AR HETEROMERS INFLUENCE MPFC..:

Gonçalves-Ribeiro, Joana ; Savchak, Oksana ; Costa-Pinto, Sara...
IBRO Neuroscience Reports. 15 (2023) - p. S228-S229 , 2023

Link: https://doi.org/10.1016/..

7

The Expression of Cellular Prion Protein, PrPC, Favors pTau..:

Rivas-Santisteban, Rafael ; Raïch, Iu ; Aguinaga Andrés, David...
Agencia Estatal de Investigación PID2020-113430RB-I00. , 2023

Link: https://ddd.uab.cat/reco..

8

Biogenic Amine Levels Markedly Increase in the Aqueous Humo..:

Lillo, Alejandro ; Marín Martínez, Silvia ; Serrano-Marín, Joan...
Reproducció del document publicat a: https://doi.org/10.3390/ijms232112752. , 2022

Link: http://hdl.handle.net/24..

9

A Single Point Mutation Blocks the Entrance of Ligands to t..:

Casajuana-Martin, Nil ; Navarro Brugal, Gemma ; Gonzalez, Angel...
Ministerio de Economía y Competitividad BES-2017-081872. , 2022

Link: https://ddd.uab.cat/reco..

10

Regulation of Expression of Cannabinoid CB2 and Serotonin 5..:

Lillo, Jaume ; Raïch, Iu ; Silva, Laura...
Reproducció del document publicat a: https://doi.org/10.3390/ijms23179695. , 2022

Link: http://hdl.handle.net/24..

11

A Single Point Mutation Blocks the Entrance of Ligands to t..:

Casajuana-Martin, Nil ; Navarro Brugal, Gemma ; González Ureña, A...
Versió postprint del document publicat a: https://doi.org/10.1021/acs.jcim.2c00865. , 2022

Link: http://hdl.handle.net/24..

12

Expression of the Adenosine A2A-A3 Receptor Heteromer in Di..:

Lillo, Alejandro ; Raïch, Iu ; Lillo, Jaume...
Reproducció del document publicat a: https://doi.org/10.3390/biomedicines10020214. , 2022

Link: http://hdl.handle.net/24..

13

Targeted Metabolomics Shows That the Level of Glutamine, Ky..:

Lillo, Alejandro ; Marín Martínez, Silvia ; Serrano-Marín, Joan...
Reproducció del document publicat a: https://doi.org/10.3389/fmed.2022.935084. , 2022

Link: http://hdl.handle.net/24..

14

N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors f..:

Rivas‐ ; Santisteban, Rafael ; Lillo, Alejandro...
Reproducció del document publicat a: https://doi.org/10.1186/s13195-021-00920-6. , 2021

Link: http://hdl.handle.net/24..

15

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neu..:

Franco Fernández, Rafael ; Rivas‐Santisteban, Rafael ; Lillo, Jaume...
Reproducció del document publicat a: https://doi.org/10.3389/fcell.2021.667815. , 2021

Link: http://hdl.handle.net/24..